nach oben

Erschienen in:

11.03.2020 | Review Article

Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia

verfasst von: Hassan Galadari, Swathi Shivakumar, Torello Lotti, Uwe Wollina, Andy Goren, Ghasem Rahmatpour Rokni, Stephan Grabbe, Mohamad Goldust

Erschienen in: Lasers in Medical Science | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Androgenetic alopecia (AGA), also termed as androgenic alopecia or common baldness, is a condition where there is androgen mediated conversion of susceptible terminal hair into vellus hair. Although it is reported more commonly in males, it also affects females but the incidence is relatively unknown. AGA tremendously affects the psychology of the patient due to its chronicity of treatment and cosmetic implications. There are numerous treatment options available for AGA but the choice of treatment has to often be tailored according to the patient’s needs, affordability, and compliance. This review focusses on the various treatment options available, with special emphasis on the role of low-level laser therapy (LLLT) in the management of AGA. The literature research considered published journal articles (clinical trials or scientific reviews). Studies were identified by searching electronic databases (MEDLINE and PubMed) and reference lists of respective articles. Only articles available in English were considered for this review.

Hamilton JB (1951) Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 53(3):708–728PubMed

Otberg N, Finner AM, Shapiro J (2007) Androgenetic Alopecia. Endocrinol Metab Clin N Am 36(2):379–398

Paus R, Cotsarelis G. The biology of hair follicles. Epstein FH, editor. N Engl J Med 1999;341(7):491–497

Rousso DE, Kim SW (2014) A review of medical and surgical treatment options for androgenetic alopecia. JAMA Facial Plast Surg 16(6):444PubMed

Avci P, Gupta GK, Clark J, Wikonkal N, Hamblin MR (2014) Low-level laser (light) therapy (LLLT) for treatment of hair loss: LLLT for hair regrowth. Lasers Surg Med 46(2):144–151PubMed

Faghihi G, Mozafarpoor S, Asilian A, Mokhtari F, Esfahani A, Bafandeh B et al (2018) The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia. Indian J Dermatol Venereol Leprol 84(5):547PubMed

Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W et al (1998) Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 39(4):578–589PubMed

Van Neste D, Fuh V, Sanchez-Pedreno P, Lopez-Bran E, Wolff H, Whiting D et al (2000) Finasteride increases anagen hair in men with androgenetic alopecia. Br J Dermatol 143(4):804–810PubMed

Caserini M, Radicioni M, Leuratti C, Terragni E, Iorizzo M, Palmieri R (2016) Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia. Int J Clin Pharmacol Ther 54(01):19–27PubMed

10.

Irwig MS (2012) Persistent sexual side effects of finasteride: could they be permanent? J Sex Med 9(11):2927–2932PubMed

11.

Finasteride for androgenetic alopecia and side effects [Internet]. [cited 2019 Sep 16]. Available from: https://www.clinicaldermatology.eu/materiale_cic/719_1_4/6207_finasteride/article.htm

12.

Hajheydari Z, Akbari J, Saeedi M, Shokoohi L (2009) Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia. Indian J Dermatol Venereol Leprol 75(1):5

13.

Drobnis EZ, Nangia AK (2017) 5α-reductase inhibitors (5ARIs) and male reproduction. Adv Exp Med Biol 1034:59–61PubMed

14.

Tsunemi Y, Irisawa R, Yoshiie H, Brotherton B, Ito H, Tsuboi R et al (2016) Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia. J Dermatol 43(9):1051–1058PubMed

15.

Prager N, Bickett K, French N, Marcovici G (2002) A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med 8(2):143–152

16.

Rossi A, Mari E, Scarnò M, Garelli V, Maxia C, Scali E et al (2012) Comparitive effectiveness and finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study. Int J Immunopathol Pharmacol 25(4):1167–1173PubMed

17.

Sovak M, Seligson AL, Kucerova R, Bienova M, Hajduch M, Bucek M (2002) Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience. Dermatol Surg 28(8):678–685PubMed

18.

Rathnayake D, Sinclair R (2010) Male androgenetic alopecia. Expert Opin Pharmacother 11(8):1295–1304PubMed

19.

Goren A, Sharma A, Dhurat R, Shapiro J, Sinclair R, Situm M et al (2018) Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients. Dermatol Ther 31(6):e12741PubMed

20.

Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S (2012) Minoxidil use in dermatology, side effects and recent patents. Recent Patents Inflamm Allergy Drug Discov 6(2):130–136

21.

Bienová M, Kuerová R, Fiurá M (2005) Androgenetic alopecia and current methods of treatment. Androg Alopecia 14(1):4

22.

Senel E, Purnak T, Sahin C (2011) Liquid formulation of minoxidil versus its foam formulation. Indian J Dermatol 56(4):462PubMedPubMedCentral

23.

Blumeyer A, Tosti A, Messenger A, Reygagne P, del Marmol V, Spuls PI et al (2011) Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. JDDG J Dtsch Dermatol Ges 9:S1–S57PubMed

24.

Gupta AK, Charrette A (2015) Topical minoxidil: systematic review and meta-analysis of its efficacy in androgenetic alopecia. Skinmed. 13(3):185–189PubMed

25.

Chitalia J, Dhurat R, Goren A, McCoy J, Kovacevic M, Situm M et al (2018) Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian subcontinent. Dermatol Ther 31(6):e12688PubMed

26.

Goren A, Shapiro J, Roberts J, McCoy J, Desai N, Zarrab Z et al (2015) Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Dermatol Ther 28(1):13–16PubMed

27.

Li ZJ, Choi H-I, Choi D-K, Sohn K-C, Im M, Seo Y-J et al (2012) Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg 38(7pt1):1040–1046PubMed

28.

Lotti T, Goren A, Verner I, D’Alessio PA, Franca K (2019) Platelet rich plasma in androgenetic alopecia: a systematic review. Dermatol Ther 32(3):e12837PubMed

29.

Cervelli V, Garcovich S, Bielli A, Cervelli G, Curcio BC, Scioli MG et al (2014) The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. Biomed Res Int 2014:1–9

30.

Puig CJ, Reese R, Peters M (2016) Double-blind, Placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia. Dermatol Surg 42(11):1243–1247PubMed

31.

Ayatollahi A, Hosseini H, Shahdi M, AhmadNasrollahi S, NassiriKashani M, Yadangi S et al (2017) Platelet-rich plasma by single spin process in male pattern androgenetic alopecia: is it an effective treatment? Indian Dermatol Online J 8(6):460–464PubMedPubMedCentral

32.

Stevens J, Khetarpal S (2019) Platelet-rich plasma for androgenetic alopecia: a review of the literature and proposed treatment protocol. Int J Womens Dermatol 5(1):46–51PubMed

33.

Schmidt B, Horsley V (2012) Unravelling hair follicle-adipocyte communication. Exp Dermatol 21(11):827–830PubMedPubMedCentral

34.

Rossi A, Anzalone A, Fortuna MC, Caro G, Garelli V, Pranteda G et al (2016) Multi-therapies in androgenetic alopecia: review and clinical experiences: an update and future potential treatments. Dermatol Ther 29(6):424–432PubMed

35.

Patwardhan N, Mysore V (2008) Hair transplantation: standard guidelines of care. Indian J Dermatol Venereol Leprol 74(Suppl):S46–53

36.

Kassimir JJ (1987) Use of topical minoxidil as a possible adjunct to hair transplant surgery. J Am Acad Dermatol 16(3):685–687PubMed

37.

Leavitt M, David P-M, Rao NA, Barusco M, Kaufman KD, Ziering C (2006) Effects of finasteride (1 mg) on hair transplant. Dermatol Surg 31(10):1268–1276

38.

Dhurat R, Mathapati S (2015) Response to microneedling treatment in men with androgenetic alopecia who failed to respond to conventional therapy. Indian J Dermatol 60(3):260PubMedPubMedCentral

39.

Verner I, Lotti T (2018) Clinical evaluation of a novel fractional radiofrequency device for hair growth: fractional radiofrequency for hair growth stimulation. Dermatol Ther 31(3):e12590PubMed

40.

Maddin WS, Bell PW, James JH (1990) The biological effects of a pulsed electrostatic field with specific reference to hair. Electrotrichogenesis Int J Dermatol 29(6):446–450PubMed

41.

Doghaim NN, El-Tatawy RA, Neinaa YME, Abd El-Samd MM (2018) Study of the efficacy of carboxytherapy in alopecia. J Cosmet Dermatol 17(6):1275–1285PubMed

42.

Ghanaat M (2010) Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism. South Med J 103(9):917–921PubMed

43.

Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR et al (2014) Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, Double-blind Study. Am J Clin Dermatol 15(2):115–127PubMedPubMedCentral

44.

Kruglikov IL, Zhang Z, Scherer PE (2019) The role of immature and mature adipocytes in hair cycling. Trends Endocrinol Metab 30(2):93–105PubMed

45.

Leavitt M, Charles G, Heyman E, Michaels D (2009) HairMax LaserComb® laser phototherapy device in the treatment of male androgenetic alopecia: a randomized, double-blind, sham device-controlled. Multicentre Trial Clin Drug Investig 29(5):283–292PubMed

46.

Kim H, Choi JW, Kim JY, Shin JW, Lee S, Huh C-H (2013) Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, Sham Device–Controlled Multicenter Trial. Dermatol Surg 39(8):1177–1183PubMed

47.

Suchonwanit P, Chalermroj N, Khunkhet S (2019) Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial. Lasers Med Sci 34(6):1107–1114PubMed

48.

Mai-Yi Fan S, Cheng Y-P, Lee M-Y, Lin S-J, Chiu H-Y (2018) Efficacy and safety of a low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, self-comparison, sham device-controlled trial. Dermatol Surg Off Publ Am Soc Dermatol Surg Al 44(11):1411–1420

49.

Lanzafame RJ, Blanche RR, Bodian AB, Chiacchierini RP, Fernandez-Obregon A, Kazmirek ER (2013) The growth of human scalp hair mediated by visible red light laser and LED sources in males: the growth of human scalp hair. Lasers Surg Med 45(8):487–495PubMed

50.

Lanzafame RJ, Blanche RR, Chiacchierini RP, Kazmirek ER, Sklar JA (2014) The growth of human scalp hair in females using visible red light laser and LED sources: growth of scalp hair in women. Lasers Surg Med 46(8):601–607PubMed

Titel: Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia
verfasst von: Hassan Galadari
Swathi Shivakumar
Torello Lotti
Uwe Wollina
Andy Goren
Ghasem Rahmatpour Rokni
Stephan Grabbe
Mohamad Goldust
Publikationsdatum: 11.03.2020
Verlag: Springer London
Erschienen in: Lasers in Medical Science / Ausgabe 6/2020
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-020-02994-4

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2020

Efficacy of low-level laser therapy on management of Bell’s palsy: a systematic review

Higher implantation and live birth rates with laser zona pellucida breaching than thinning in single frozen-thawed blastocyst transfer

Efficacy and outcome of holmium laser enucleation of prostate in patients with urinary retention due to advanced prostate cancer

Determination and analysis of singlet oxygen quantum yields of talaporfin sodium, protoporphyrin IX, and lipidated protoporphyrin IX using near-infrared luminescence spectroscopy

Effect of different laser types on bonding strength of CAD/CAM-customized zirconia post to root canal dentin: an experimental study

Physical exercise and low-level laser therapy on the nociception and leukocyte migration of Wistar rats submitted to a model of rheumatoid arthritis